|
|
|
    |
| | | | | |||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
 Download the PDF version.
Business WireTestosterone, Blood Flow, or Sensation? Which is Key to Unlocking Women's Desire and Sexual Pleasure?; Ask Experts What Works July 07, 2005 04:13 PM US Eastern Timezone
CHARLESTON, S.C.--(BUSINESS WIRE)--July 7, 2005--New studies and journal articles have raised serious questions about what really works to improve sex for women. Testosterone and blood flow appear to be taking a back seat to sensation. The July 6, 2005, article in the Journal of the American Medical Association reports the finding that, "No single androgen (sex hormone) level was found to be predictive of low sexual function in women."(1) This follows rapidly on a May 2005 study published in the American Journal of Obstetrics & Gynecology by researchers at Yale School of Medicine and the Albert Einstein College of Medicine. The study reported that, "Decreased tactile sensation was found at the clitoris for women with total sexual dysfunction, desire disorder and arousal disorder."(2) "In addition to reports of low sex drive, women's health professionals often hear that some women 'feel dead down there,'" said gynecologist Elizabeth Baron-Kuhn. "Women are clearly more complex than men, and these new findings help to illuminate the underlying reasons why major drug companies have yet to succeed in developing an FDA approved prescription drug for women's sexual problems." "It's time to recognize the required role that sensation has in female sexual response and explore non-hormonal options that can lift libido and make sex better for women," added Dr. Baron-Kuhn. The following medical and sexual health experts are available for comment as non-paid members of a newly formed Sexual Wellness Panel:
-- Elizabeth Baron-Kuhn, MD, FACOG - A Board Certified
Gynecologist at Riverside Gynecology and Women's Health in
Waupaca, Wisconsin. With expertise in menopause and female
sexual dysfunction, Dr. Baron-Kuhn initiated and delivered a
two-year public health lecture series on topics centered
around menopause and women's health including: "Understanding
Menopause: What's Happening to Me?"
-- Andre Theodore Guay, MD - A clinical assistant professor of
medicine at Harvard Medical School and Director of the Center
For Sexual Dysfunction at Lahey Clinic Northshore in Peabody
and a senior staff physician in the Department of
Endocrinology at the Lahey Clinic Medical Center, Burlington,
MA.
-- Harold Schulman, MD - Coauthor of Tipping The Scales, former
professor at State University of New York at Stony Brook and
former chairman of obstetrics/gynecology at Albert Einstein
College of Medicine. Dr. Schulman is today a consultant and
teacher in female ultrasound. He is working on a new book in
the field of women's sexual power in societal affairs.
-- Rosemarie Schulman, RN, BA, CH - Coauthor of Tipping the
Scales and a radio and TV host. Established several health
care centers incorporating alternative medicine in weight
management. Currently heads the dietary and behavior
management at the New York Medical College Bariatric Surgery
division. In her work, Schulman addresses the association
between weight-loss and sexual dysfunction.
-- Susan Kellogg-Spadt, PhD, CRNP - Co-founder of the Pelvic &
Sexual Health Institute at Graduate Hospital in Philadelphia
where she has been the Director of Sexual Medicine for seven
years. Dr. Kellogg-Spadt is also an assistant professor of
OB/GYN at Robert Wood Johnson Medical School of the University
of Medicine & Dentistry of New Jersey. In addition, Dr.
Kellogg-Spadt has authored two books and more than 80 articles
on women's sexual health.
The panel members will speak objectively about multidisciplinary approaches to improve sexual experiences for women, as part of a public education campaign. The campaign is supported by QualiLife Pharmaceuticals, developers of Zestra(TM) for Women. Zestra(TM) has been acknowledged in leading peer reviewed medical journals.
-- Obstetrical and Gynecological Survey - Continuing Medical
Education (CME) Review
In March 2005, Obstetrical and Gynecological Survey published
a Continuing Medical Education (CME) Review Article that
acknowledges the benefits of Zestra(TM) for both arousal and
orgasmic difficulties. The objective of the CME Review Article
titled "Female Sexual Dysfunction: Principles of Therapy" is
to provide the most current clinical information available to
Obstetricians and Gynecologists on the topic of female sexual
dysfunction and the principles of diagnosis and therapy.
The CME Review Article cites a clinical trial conducted by
QualiLife Pharmaceuticals titled "Randomized
Placebo-Controlled Double Blind, Crossover Design Trial of the
Efficacy and Safety of Zestra for Women in Women With, and
Without Female Sexual Arousal Disorder (FSAD)." The study of
20 women showed improvement in level of desire, arousal,
sensation, pleasure and ability to have orgasms in both normal
and FSAD patients using Zestra(TM), as compared with placebo.
To view the article abstract visit Obstetrical and
Gynecological Survey's Web site at www.obgynsurvey.com.
-- Association of Reproductive Health Professionals (ARHP)
Clinical Proceedings(R)
In May 2005, ARHP published Clinical Proceedings that is
designated for Continuing Medical Education (CME).
Clinical Proceedings also cites the clinical trial
referenced above and recognizes Zestra(TM) as a treatment
option for females with sexual arousal difficulties.
Clinical Proceedings is part of a Nurture Your Nature
initiative, a joint program of ARHP and the National
Women's Health Resource Center to raise awareness about
sexuality as a natural and valued aspect of American
women's lives, with a focus on menopausal women. For
full-text: http://www.healthywomen.org/sexuality/CPNYN.pdf.
About Non-Prescription Zestra(TM) Feminine Arousal Fluid (U.S. Patent 6,737,084) Zestra(TM) is a patented blend of pure botanical oils and other natural ingredients scientifically formulated to heighten sexual sensation, arousal and pleasure for 30 to 45 minutes when topically applied. The ingredients in Zestra(TM) are not found in any other women's sexual product. No other product is proven to be more effective for increasing female sexual sensation, arousal, pleasure, satisfaction and libido. Ingredients: PA-Free Borage Seed Oil, Evening Primrose Oil, Angelica Extract, Coleus Extract, Vitamin C, Vitamin E and natural fragrances. More information is available at www.zestraforwomen.com. Zestra(TM) is available nationwide in Walgreen's, CVS and Duane Reade pharmacies. About QualiLife Pharmaceuticals, Inc. QualiLife Pharmaceuticals, Inc. is a science-driven company focused on developing clinically proven consumer products for Women's Health. Since 1996, the Company has leveraged its expertise in pharmacology, pharmaceutical technology and women's sexual health to "design and develop" selected plant-derived principles as patented consumer products with significant commercial potential. (1)Journal of the American Medical Association, July 6, 2005; vol 294: pp 91-96. Susan Davis, MD, PhD, Women's Health Program, Department of Medicine, Monash Medical School, Alfred Hospital, Victoria, Australia.
(2)American Journal of Obstetrics & Gynecology, Vol. 192, No. 5 (May 2005), Kathleen Connell, MD; Marsha K. Guess, MD; Julie La Combe, MD; Andrea Wang, MD; Kenneth Powers, MD; George
Lazarou, MD; Magdy Mikhail, MD; Yale School of Medicine and the Albert Einstein College of Medicine.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed& Source: Zestra Laboratories, Inc. |
|
 | |||||
| |||||
